TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 1, 2023. Registration Statement No. 333-271611 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 Copies to: to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Addex Therapeutics Ltd (Exact name of registrant as specified in its charter) 2834 Switzerland (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Chem ...